Cryo-Cell International (CCEL) vs NewGenIvf Group (NIVF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cryo-Cell International is the larger company by market cap ($31.5 million vs $2.9 million), about 10.9 times the size. On valuation, NewGenIvf Group trades at a lower forward P/E (0.0x vs 195.5x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CCEL | NIVF |
|---|---|---|
| Share price | $3.91 | $0.106 |
| Market cap | $31.52M | $2.89M |
| 1-day change | +0.77% | +7.40% |
| YTD return | +13.66% | — |
| 1-year return | -11.34% | — |
| 5-year return | -70.27% | — |
| P/E ratio (TTM) | — | 0.00 |
| Forward P/E | 195.50 | 0.00 |
| EPS (TTM) | $-0.31 | $355.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.90 | $1,539.00 |
| 52-week low | $2.72 | $0.064 |
| Distance from 52-week high | -20.20% | -99.99% |
| Average volume | 23.63K | 21.47M |
| Shares outstanding | 8.06M | 27.29M |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cryo-Cell International is about 10.9 times larger than NewGenIvf Group by market value ($31.52M vs $2.89M).
CCEL vs NIVF FAQ
Which is bigger, Cryo-Cell International or NewGenIvf Group?
Cryo-Cell International (CCEL) is larger, with a market capitalization of $31.52M compared with $2.89M for NewGenIvf Group (NIVF).
Are Cryo-Cell International and NewGenIvf Group in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.